miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway

Liang Shi, Fang Zheng, Jianjian Zheng et al.|Asian Pacific Journal of Cancer Prevention|2015

Cited by 89